重药控股 (000950)
C.Q. Pharmaceutical Holding Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 172818.47
- Circulating A-Shares(W): 172818.47
- Earnings Per Share(RMB): 0.2200
- Net Assets Per Share(RMB): 6.6869
- Operating Revenue(W RMB): 6221140.19
- Total Profit(W RMB): 65743.62
- Net Profit Attributable to Parent(W RMB): 38401.03
- Net Profit Growth Rate(%): 31.41
- Weighted Return on Equity(%): 3.3500
- Operating Cash Flow Per Share(RMB): -1.3480
- Undistributed Profit Per Share(RMB): 4.2674
- Capital Reserve Per Share(RMB): 1.4274
2. Main Business
The main business covers:
- Pharmaceutical Commerce
- Warehousing and Logistics
- Pharmaceutical Industry
- Pharmaceutical R&D
3. Company Basic Information
- Company Name: C.Q. Pharmaceutical Holding Co., Ltd.
- Listing Date: 1999-09-16
- Industry: Wholesale (Tongdaxin Research Industry: Medicine & Medical - Pharmaceutical Commerce)
- Address: No. 303 Jinshi Avenue, Yubei District, Chongqing, China
- Website: www.cqphar.com
- Company Profile: The company was established as a joint-stock limited company on May 28, 1999, through the restructuring of Chongqing Pesticide & Chemical (Group) Co., Ltd., jointly initiated with four other sponsors: Chongqing Tianyuan Chemical Plant, Chongqing Jialing Chemical Products Co., Ltd., Chongqing Kangda Machinery Manufacturing Co., Ltd., and Nanhai Gaoli Industrial Co., Ltd. The sponsors contributed their operating assets in exchange for 100 million sponsor shares. Following the issuance of 49.5 million public shares and the placement of 5.5 million ordinary shares (RMB) to securities investment funds on August 11, 1999, totaling 55 million shares, the company's total share capital reached 155 million shares. The 55 million public shares were listed on the Shenzhen Stock Exchange on September 16, 1999. After this issuance, the total share capital was 155 million shares. On August 27, 1999, the company completed the registration change with the Chongqing Administration for Industry and Commerce, changing its registered capital to 155 million yuan.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Chongqing Pharmaceutical Health Industry Co., Ltd. | General Legal Person | 66490.08 | 38.47 |
| 2 | Chongqing City Construction Investment (Group) Co., Ltd. | General Legal Person | 28229.44 | 16.33 |
| 3 | Chongqing Yufu Capital Equity Investment Fund Management Co., Ltd. - Chongqing Strategic Emerging Industry Pharmaceutical Special Equity Investment Fund Partnership (Limited Partnership) | Asset Management Plan | 5559.25 | 3.22 |
| 4 | Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. | General Legal Person | 2599.23 | 1.50 |
| 5 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | General Legal Person | 1718.67 | 0.99 |
| 6 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1009.10 | 0.58 |
| 7 | Southern China Securities CSI 1000 Exchange Traded Open-End Index Securities Investment Fund | Fund | 789.76 | 0.46 |
| 8 | <值> | <值> | <值> | <值> |
| 9 | <值> | <值> | <值> | <值> |
| 10 | <值> | <值> | <值> | <值> |
5. Concept Sectors
- Venture Capital
- New Retail
- Baby & Child Concept
- Elderly Care Concept
- Intelligent Machines
- Gene Concept
- Smart Healthcare
- Cold Chain Logistics
- Assisted Reproduction
- Innovative Drugs
- Weight Loss Drugs
- Margin Trading & Securities Lending
- Low Price-to-Book Ratio
- Below Net Asset Value
- Share Buyback Plan
- High Accounts Receivable
- Special Loans
- CSI Central SOEs
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information